These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12802717)

  • 1. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
    Herrera-Arellano A; Rodríguez-Soberanes A; de los Angeles Martínez-Rivera M; Martínez-Cruz E; Zamilpa A; Alvarez L; Tortoriello J
    Planta Med; 2003 May; 69(5):390-5. PubMed ID: 12802717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole.
    Herrera-Arellano A; Jiménez-Ferrer E; Vega-Pimentel AM; Martínez-Rivera Mde L; Hernández-Hernández M; Zamilpa A; Tortoriello J
    Planta Med; 2004 Jun; 70(6):483-8. PubMed ID: 15241887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
    Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
    Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Martínez-Rivera Mde L; Rodríguez-Tovar AV; Herrera-Alvarez S; Salas-Andonaegui ML; Nava-Xalpa MY; Méndez-Salas A; Tortoriello J
    Planta Med; 2009 Apr; 75(5):466-71. PubMed ID: 19189246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
    Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
    Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effectiveness of Ageratina pichinchensis on the treatment of chronic interdigital tinea pedis: a randomized, double-blind clinical trial.
    Romero-Cerecero O; Zamilpa A; Jiménez-Ferrer E; Tortoriello J
    J Altern Complement Med; 2012 Jun; 18(6):607-11. PubMed ID: 22784348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind clinical trial for evaluating the effectiveness and tolerability of Ageratina pichinchensis extract on patients with mild to moderate onychomycosis. A comparative study with ciclopirox.
    Romero-Cerecero O; Zamilpa A; Jiménez-Ferrer JE; Rojas-Bribiesca G; Román-Ramos R; Tortoriello J
    Planta Med; 2008 Oct; 74(12):1430-5. PubMed ID: 18671197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of itraconazole for the treatment of Tinea cruris, Tinea corporis and Tinea pedis interdigital].
    Zaitz C; Ruiz LR; Drullis EM; Gurfinkel P; Ciarnuto MA
    Rev Inst Med Trop Sao Paulo; 1990; 32(4):299-303. PubMed ID: 1966257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK; Skinner AR; Cooper EA
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.
    Herrera-Arellano A; López-Villegas EO; Rodríguez-Tovar AV; Zamilpa A; Jiménez-Ferrer E; Tortoriello J; Martínez-Rivera MA
    Afr J Tradit Complement Altern Med; 2013; 10(3):410-7. PubMed ID: 24146467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solanum chrysotrichum (Schldl.) a plant used in Mexico for the treatment of skin mycosis.
    Lozoya X; Navarro V; García M; Zurita M
    J Ethnopharmacol; 1992 Apr; 36(2):127-32. PubMed ID: 1608268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F; Gartmann H; Weidinger G
    Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial to compare the effectiveness of two concentrations of the Ageratina pichinchensis extract in the topical treatment of onychomycosis.
    Romero-Cerecero O; Román-Ramos R; Zamilpa A; Jiménez-Ferrer JE; Rojas-Bribiesca G; Tortoriello J
    J Ethnopharmacol; 2009 Oct; 126(1):74-8. PubMed ID: 19683043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE; Vlahovic TC
    J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis.
    Elewski BE; Jones T; Zaias N
    Cutis; 1996 Oct; 58(4):305-7. PubMed ID: 8894432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the efficacy between two itraconazole generic products and the innovative itraconazole in the treatment of tinea pedis.
    Hoharitanon S; Chaichalotornkul J; Sindhupak W
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S167-72. PubMed ID: 16623023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural changes on clinical isolates of Trichophyton rubrum, Trichophyton mentagrophytes, and Microsporum gypseum caused by Solanum chrysotrichum saponin SC-2.
    López-Villegas EO; Herrera-Arellano A; de Los Angeles Martínez-Rivera M; Alvarez L; Cano-Nepauseno M; Marquina S; Rodríguez-Tovar AV; Tortoriello J
    Planta Med; 2009 Nov; 75(14):1517-20. PubMed ID: 19551614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.